Categories

Mylan Pharmaceuticals Inc., a Viatris Company, Conducting Voluntary Recall of One Batch of Semglee® (insulin glargine injection), 100 units/mL (U-100), 3 mL Prefilled Pens, Due to the Potential for a Missing Label in the Batch

Mylan Pharmaceuticals Inc., a Viatris company, is voluntarily recalling one batch of its non-interchangeable Semglee® (insulin glargine injection), 100 units/ml (U-100), 3mL prefilled pens, which are packaged in a labelled carton of five (5) pens. The product is being recalled due to the potential f

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/mylan-pharmaceuticals-inc-viatris-company-conducting-voluntary-recall-one-batch-semgleer-insulin

 
Categories

Ingresos hospitalarios COVID-19 se duplicaron en segunda semana de enero

Ingresos hospitalarios COVID-19 se duplicaron en segunda semana de enero

Ingresos hospitalarios COVID-19 se duplicaron en segunda semana de eneroMartes 18 de enero, 2022. La segunda semana de enero registró una duplicación de los ingresos hospitalarios en comparación

https://www.ministeriodesalud.go.cr/index.php/centro-de-prensa/noticias/746-noticias-2021/2257-ingresos-hospitalarios-covid-19-se-duplicaron-en-segunda-semana-de-enero